NTRK1 and neoplasm: To clarify whether the reduced AXL levels in the serum of the patients could be explained either by the tumor down-regulating this tyrosine kinase receptor AXL or by intervention through surgery or neoadjuvant radiation therapy in these patients, the correlation between the time of blood sampling relative to the operation was examined.